These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 3042432)

  • 21. Probenecid inhibition of bumetanide-induced natriuresis in the dog.
    Holland SD; Williamson HE
    Proc Soc Exp Biol Med; 1979 Jul; 161(3):299-302. PubMed ID: 461455
    [No Abstract]   [Full Text] [Related]  

  • 22. Comparative acute ototoxicity of intravenous bumetanide and furosemide in the pure-bred beagle.
    Brown RD; Manno JE; Daigneault EA; Manno BR
    Toxicol Appl Pharmacol; 1979 Mar; 48(1 Pt 1):157-69. PubMed ID: 452038
    [No Abstract]   [Full Text] [Related]  

  • 23. [Effect of glibenclamide therapy on carbohydrate and lipid metabolism and insulin secretion in patients with glucose tolerance disorders : a 5-year study].
    Ratzmann KP; Witt S; Schulz B; Jahr D; Heinke P
    Z Gesamte Inn Med; 1981 Dec; 36(23):913-7. PubMed ID: 6805141
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term changes in insulin action and insulin secretion associated with gain, loss, regain and maintenance of body weight.
    Weyer C; Hanson K; Bogardus C; Pratley RE
    Diabetologia; 2000 Jan; 43(1):36-46. PubMed ID: 10663214
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Switching from high-fat to low-fat diet normalizes glucose metabolism and improves glucose-stimulated insulin secretion and insulin sensitivity but not body weight in C57BL/6J mice.
    Agardh CD; Ahrén B
    Pancreas; 2012 Mar; 41(2):253-7. PubMed ID: 22158067
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acute disruption of glucagon secretion or action does not improve glucose tolerance in an insulin-deficient mouse model of diabetes.
    Steenberg VR; Jensen SM; Pedersen J; Madsen AN; Windeløv JA; Holst B; Quistorff B; Poulsen SS; Holst JJ
    Diabetologia; 2016 Feb; 59(2):363-70. PubMed ID: 26537124
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The antidiabetic action of camel milk in experimental type 2 diabetes mellitus: an overview on the changes in incretin hormones, insulin resistance, and inflammatory cytokines.
    Korish AA
    Horm Metab Res; 2014 Jun; 46(6):404-11. PubMed ID: 24627103
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Investigation of the photochemical properties and in vitro phototoxic potential of bumetanide.
    Fiori J; Ballardini R; Hrelia P; Andrisano V; Tarozzi A; Cavrini V
    Photochem Photobiol Sci; 2003 Oct; 2(10):1011-7. PubMed ID: 14606756
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of bumetanide on cation and anion transport.
    Lant AF
    Postgrad Med J; 1975; 51 Suppl 6():35-42. PubMed ID: 1105531
    [No Abstract]   [Full Text] [Related]  

  • 30. Effect of cerebrocrast, a new long-acting compound on blood glucose and insulin levels in rats when administered before and after STZ-induced diabetes mellitus.
    Briede J; Stivrina M; Stoldere Dz; Vigante B; Duburs G
    Cell Biochem Funct; 2007; 25(6):673-80. PubMed ID: 16986170
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prepregnancy weight and antepartum insulin secretion predict glucose tolerance five years after gestational diabetes mellitus.
    Metzger BE; Cho NH; Roston SM; Radvany R
    Diabetes Care; 1993 Dec; 16(12):1598-605. PubMed ID: 8299456
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Department of Medicina, Faculdade de Medicina da Universidade de São Paulo, Brazil.
    Pupo AA; Ursich MJ; Iamaguchi E; Vasconcellos FG
    Diabetes; 1976 Mar; 25(3):161-6. PubMed ID: 1254108
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impaired glucose-stimulated insulin secretion is coupled with exocrine pancreatic lesions in the Cohen diabetic rat.
    Weksler-Zangen S; Raz I; Lenzen S; Jörns A; Ehrenfeld S; Amir G; Oprescu A; Yagil Y; Yagil C; Zangen DH; Kaiser N
    Diabetes; 2008 Feb; 57(2):279-87. PubMed ID: 17977959
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diazoxide causes recovery of beta-cell glucose responsiveness in 90% pancreatectomized diabetic rats.
    Leahy JL; Bumbalo LM; Chen C
    Diabetes; 1994 Feb; 43(2):173-9. PubMed ID: 8288040
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effects of bumetanide on renal function and blood composition in sheep.
    Pickering EC; Williams JH; Ergene N
    Res Vet Sci; 1976 Nov; 21(3):259-63. PubMed ID: 1030818
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of probenecid on response to bumetanide in man.
    Brater DC; Chennavasin P
    J Clin Pharmacol; 1981 Jul; 21(7):311-5. PubMed ID: 7263930
    [TBL] [Abstract][Full Text] [Related]  

  • 37. L-Asparaginase diabetes mellitus in rabbits: differing effects of two different schedules of L-asparaginase administration.
    Lavine RL; DiCinto DM
    Horm Metab Res; 1984 Dec; 16 Suppl 1():92-6. PubMed ID: 6398268
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ability of omega-3 fatty acids to restore the impaired glucose tolerance in a mouse model for type-2 diabetes. Different effects in male and female mice.
    Islin H; Capito K; Hansen SE; Hedeskov CJ; Thams P
    Acta Physiol Scand; 1991 Oct; 143(2):153-60. PubMed ID: 1962521
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Carbohydrate metabolic changes in cystic fibrosis].
    García-García E; López-Siguero JP; Olveira C; Pérez-Ruiz E; García JM; Pérez-Frías J; Martínez-Valverde A
    Med Clin (Barc); 1999 Nov; 113(16):601-3. PubMed ID: 10609251
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bumetanide reduces insulin release by a direct effect on the pancreatic beta-cells.
    Sandström PE
    Eur J Pharmacol; 1990 Oct; 187(3):377-83. PubMed ID: 1963593
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.